On the contrary, DDR2 inhibitor WRG-28 suppressed the cell proliferation of EPI-resistant breast cancer cell lines (M-EPIR and 231-EPIR), in which DDR2 expression was significantly increased compared to parental cell lines. Here, DDR2 is linked to breast cancer.